Receptor, Melanocortin, Type 4, agonists
- Name
- Receptor, Melanocortin, Type 4, agonists
- Accession Number
- DBCAT002830
- Description
Not Available
- Drugs
Drug Drug Description Bremelanotide Bremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of... Setmelanotide Setmelanotide is indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome. PF-00446687 PF-00446687 has been investigated for the treatment of Erectile Dysfunction. - Drugs & Drug Targets